Good evening :)
Place Order
Add to Watchlist

Sun Pharma Advanced Research Co Ltd

SPARC

Sun Pharma Advanced Research Co Ltd

SPARC
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,121 cr, stock is ranked 673
High RiskStock is 3.40x as volatile as Nifty
216.780.10% (+0.22)
216.780.10% (+0.22)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,121 cr, stock is ranked 673
High RiskStock is 3.40x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,121 cr, stock is ranked 673
High RiskStock is 3.40x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-17.4356.64
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.906.610.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy).

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2023FY 2024TTM
Total Revenue249.66105.0272.48
Raw Materialssubtract0.000.00464.81
Power & Fuel Costsubtract5.756.14
Employee Costsubtract107.00141.84
Selling & Administrative Expensessubtract289.71267.06
Operating & Other expensessubtract50.3862.60
Depreciation/Amortizationsubtract11.7712.5112.53
Interest & Other Itemssubtract7.631.692.87
Taxes & Other Itemssubtract0.000.380.94
EPS-6.86-11.93-12.59
DPS0.000.000.00
Payout ratio0.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2017

Annual report

PDF

Investor Presentation

Aug 4PDF
FY 2019

Annual report

PDF

Investor Presentation

Sep 4PDF
FY 2020

Annual report

PDF

Investor Presentation

Sep 19PDF
FY 2021

Annual report

PDF

Investor Presentation

Sep 10PDF
FY 2022

Annual report

PDF

Investor Presentation

Dec 28PDF
Dec 16PDF
Dec 9PDF
FY 2023

Annual report

PDF

Investor Presentation

Oct 28PDF
Oct 17PDF
Oct 13PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Sun Pharma Advanced Research Co Ltd-18.3956.64
Sun Pharmaceutical Industries Ltd45.106.440.75%
Cipla Ltd29.414.520.87%
Torrent Pharmaceuticals Ltd68.5016.550.84%

Price Comparison

Compare SPARC with any stock or ETF
Compare SPARC with any stock or ETF
SPARC
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding

Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding65.67%0.10%0.12%2.15%31.95%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep3.64%3.67%3.30%3.23%2.64%2.15%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Sun Pharma Advanced Research Co Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Plan Growth

Growth
0.3994%0.57%0.57%38/51 (+7)
Nippon India Nifty Smallcap 250 Index Fund - Growth - Direct Plan

Growth
0.0308%0.11%-0.01%27/294 (-1)
SBI Nifty Smallcap 250 Index Fund - Direct Plan - Growth

Growth
0.0187%0.11%-0.01%139/294 (0)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

SPARC has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Spotlight
Volumes jump at Sun Pharma Advanced Research Company Ltd counter

Raymond Ltd, Praj Industries Ltd, Adani Green Energy Ltd, Mangalore Refinery And Petrochemicals Ltd are among the other stocks to see a surge in volumes on NSE today, 22 November 2024.Sun Pharma Advanced Research Company Ltd witnessed volume of 40.83 lakh shares by 14:14 IST on NSE, a 13.33 times surge over two-week average daily volume of 3.06 lakh shares. The stock increased 8.35% to Rs.206.23. Volumes stood at 2.59 lakh shares in the last session.Raymond Ltd recorded volume of 17.78 lakh shares by 14:14 IST on NSE, a 12.91 times surge over two-week average daily volume of 1.38 lakh shares. The stock gained 8.45% to Rs.1,547.45. Volumes stood at 1.68 lakh shares in the last session.Praj Industries Ltd notched up volume of 51.83 lakh shares by 14:14 IST on NSE, a 12.5 fold spurt over two-week average daily volume of 4.15 lakh shares. The stock rose 9.73% to Rs.741.20. Volumes stood at 3.12 lakh shares in the last session.Adani Green Energy Ltd saw volume of 168.43 lakh shares by 14:14 IST on NSE, a 8.88 fold spurt over two-week average daily volume of 18.97 lakh shares. The stock dropped 4.30% to Rs.1,096.40. Volumes stood at 95.24 lakh shares in the last session.Mangalore Refinery And Petrochemicals Ltd notched up volume of 202.28 lakh shares by 14:14 IST on NSE, a 8.26 fold spurt over two-week average daily volume of 24.50 lakh shares. The stock rose 6.57% to Rs.154.58. Volumes stood at 14.9 lakh shares in the last session.Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Spotlight
SPARC drops as Q2 net loss widens to Rs 107 crore

Net sales declined 39.29% year on year (YoY) to 12.86 crore in the quarter ended 30 September 2024. Total expenses rose 3.43% YoY to Rs 120.07 crore in September 2024 quarter. Employee benefit expenses was Rs 38.48 crore (up 25.3% YoY), professional charges stood at Rs 30.75 crore (down 26.58% YoY), clinical trial expenses at Rs 25.53 crore (up 40.2% YoY). Sun Pharma Advanced Research Company (SPARC) is a pharmaceutical company focused on continuously improving standards of care for patients globally through innovation in therapeutics and delivery.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 107.33 crore in the September 2024 quarter

Net Loss of Sun Pharma Advanced Research Company reported to Rs 107.33 crore in the quarter ended September 2024 as against net loss of Rs 86.42 crore during the previous quarter ended September 2023. Sales declined 39.28% to Rs 12.86 crore in the quarter ended September 2024 as against Rs 21.18 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.8621.18 -39 OPM %-800.23-431.87 - PBDT-104.01-83.24 -25 PBT-107.17-86.42 -24 NP-107.33-86.42 -24 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Sun Pharma Advanced Research Company to convene board meeting

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on 4 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live

Sun Pharma Advanced Research Company reports consolidated net loss of Rs 95.90 crore in the June 2024 quarter

4 months agoBusiness Standard
Earnings
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 95.90 crore in the June 2024 quarter

Net Loss of Sun Pharma Advanced Research Company reported to Rs 95.90 crore in the quarter ended June 2024 as against net loss of Rs 95.35 crore during the previous quarter ended June 2023. Sales declined 29.81% to Rs 16.81 crore in the quarter ended June 2024 as against Rs 23.95 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales16.8123.95 -30 OPM %-555.38-426.64 - PBDT-92.36-92.25 0 PBT-95.50-95.35 0 NP-95.90-95.35 -1 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Sun Pharma Advanced Research Company announces board meeting date

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on 5 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live

Sun Pharma Advanced Research loss widens to Rs 81.99 cr in March quarter

1 year agoBusiness Standard

Sun Pharma Advanced Research Company falls 5% as quarterly loss widens to Rs 82 crore

1 year agoMoneycontrol

Sun Pharma may incur revenue loss for ransomware incident on March 2

1 year agoBusiness Standard